AEHR shareholder plans sale of 3,000 shares

A shareholder of AEHR has filed a Rule 144 notice to sell 3,000 shares of common stock, with an aggregate market value of $82,715.25.

Accepted by SEC EDGAR 02/09/2026 - 04:52 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

A shareholder of AEHR has filed a Rule 144 notice to sell 3,000 shares of common stock, with an aggregate market value of $82,715.25. The planned sale is through Fidelity Brokerage Services LLC on the NASDAQ, with an approximate sale date of 02/09/2026.

The filing notes that 30,627,342 shares of common stock were outstanding. The 3,000 shares to be sold were acquired through multiple restricted stock vesting compensation events between 10/02/2025 and 01/27/2026, with each vesting treated as compensation from the issuer.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does AEHRs latest Form 144 filing disclose?

The Form 144 shows a shareholder plans to sell 3,000 AEHR common shares under Rule 144. The planned sale, valued at $82,715.25, will be executed through Fidelity Brokerage Services LLC on the NASDAQ around 02/09/2026.

How many AEHR shares are being sold and at what market value?

The filing covers a proposed sale of 3,000 AEHR common shares with an aggregate market value of $82,715.25. This amount is based on market pricing at the time of the notice and reflects the value of the specific block registered for sale.

On which exchange and through which broker will the AEHR shares be sold?

The 3,000 AEHR common shares are planned to be sold on the NASDAQ market. The transaction will be handled by Fidelity Brokerage Services LLC, located at 900 Salem Street, Smithfield, RI 02917, as listed in the Form 144 filing.

How many AEHR shares were outstanding when this Form 144 was filed?

The notice reports that 30,627,342 AEHR common shares were outstanding. This number provides context for the size of the 3,000-share planned sale, indicating the transaction is small relative to the total shares outstanding at that time.

How did the seller acquire the AEHR shares being sold under Rule 144?

The shares were acquired through multiple restricted stock vesting transactions from the issuer. Vesting dates range from 10/02/2025 to 01/27/2026, with amounts such as 462, 602, and 551 shares per vesting, all categorized as compensation.

Are the AEHR shares in the Form 144 filing related to compensation?

Yes. The filing shows each acquisition of AEHR common stock is labeled as Restricted Stock Vesting with the nature of payment listed as Compensation. This indicates the seller received these shares from the issuer as part of equity-based compensation awards.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001939261
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	AEHR TEST SYSTEMS
SEC File Number	000-22893
Address of Issuer	400 KATO TERRACE FREMONT CALIFORNIA 94539
Phone	5106239400
Name of Person for Whose Account the Securities are To Be Sold	SPORCK ALISTAIR N
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	3000	82715.25	30627342	02/09/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/02/2025	Restricted Stock Vesting	Issuer			462	10/02/2025	Compensation
Common	10/11/2025	Restricted Stock Vesting	Issuer			371	10/11/2025	Compensation
Common	10/18/2025	Restricted Stock Vesting	Issuer			602	10/18/2025	Compensation
Common	10/27/2025	Restricted Stock Vesting	Issuer			236	10/27/2025	Compensation
Common	01/02/2026	Restricted Stock Vesting	Issuer			222	01/02/2026	Compensation
Common	01/11/2026	Restricted Stock Vesting	Issuer			340	01/11/2026	Compensation
Common	01/18/2026	Restricted Stock Vesting	Issuer			551	01/18/2026	Compensation
Common	01/27/2026	Restricted Stock Vesting	Issuer			216	01/27/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	02/09/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Gerardo Ibarra-Munoz, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Alistair N. Sporck
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)